In silico and in vitro anti-inflammatory study of phenolic compounds isolated from Eucalyptus maculata resin
| dc.Affiliation | October University for modern sciences and Arts MSA | |
| dc.contributor.author | Ali1, Dalia E | |
| dc.contributor.author | El Gedaily, Rania A | |
| dc.contributor.author | Ezzat, Shahira M | |
| dc.contributor.author | El Sawy, Maged A | |
| dc.contributor.author | Meselhy, Meselhy R | |
| dc.contributor.author | Abdel‑Sattar, Essam | |
| dc.date.accessioned | 2023-02-13T08:05:17Z | |
| dc.date.available | 2023-02-13T08:05:17Z | |
| dc.date.issued | 2023-02-06 | |
| dc.description | SJR 2024 0.874 Q1 H-Index 347 | |
| dc.description.abstract | Plant resins are rich in bioactive compounds with high medicinal values. However, the chemistry and anti-inflammatory activity of the resins produced by trees of the genus Eucalyptus were scarcely investigated. The inflammatory targets cyclooxygenase-1 (COX-1), COX-2, TNF-, NF-B, and NO were significantly inhibited by the methanolic extract of Eucalyptus maculata kino resin (EME) and its CH2Cl2 soluble fraction (MCF). Sakuranetin (C1), (E)-cinnamic acid (C2), kaempferol 7- methyl ether (C3), 7-O-methyl aromadendrin (C4), and 1,6- dicinnamoyl-O-α-D-glucopyranoside (C5) were isolated from MCF. Three compounds (C1, C2, and C4) showed potent in vitro COX-1 inhibition, while C5 inhibited COX-2, TNF-α, NF-κB, and NO significantly. An in-silico study revealed that C5 had the highest binding affinity to the active site in COX-2 with binding energy score (S) of -14.85 kcal/mol, better than celecoxib (COX-2 inhibitor). In conclusion, 1,6-dicinnamoyl-O-α-D-glucopyranoside (C5) could be investigated further in the search for anti-inflammatory agents. | en_US |
| dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=21100200805&tip=sid&clean=0 | |
| dc.identifier.citation | Ali, D. E., Rania, Ezzat, S. M., Maged, Meselhy, M. R., & Essam Abdel-Sattar. (2023). In silico and in vitro anti-inflammatory study of phenolic compounds isolated from Eucalyptus maculata resin. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-28221-y | |
| dc.identifier.doi | https://doi.org/10.1038/s41598-023-28221-y | |
| dc.identifier.other | https://doi.org/10.1038/s41598-023-28221-y | |
| dc.identifier.uri | http://repository.msa.edu.eg/xmlui/handle/123456789/5341 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | Nature Publishing Group | en_US |
| dc.relation.ispartofseries | Scientific Reports volume 13, Article number: 2093 (2023) | |
| dc.subject | silico and in vitro | en_US |
| dc.subject | anti‑infammatory | en_US |
| dc.subject | phenolic compounds isolated | en_US |
| dc.subject | resin | en_US |
| dc.title | In silico and in vitro anti-inflammatory study of phenolic compounds isolated from Eucalyptus maculata resin | en_US |
| dc.type | Article | en_US |
